Beauty Health Q2 2021 Earnings Report
Key Takeaways
The Beauty Health Company reported exceptional second-quarter results with a 371.2% increase in net sales compared to Q2 2020, driven by strong performance in both Delivery Systems and Consumables. The company is raising its full-year sales guidance to $230 million to $240 million.
Net sales increased by 371.2% to $66.5 million compared to Q2 2020.
Delivery System net sales increased to $34.9 million, while Consumables net sales increased to $31.6 million.
Gross margin increased to 71.0% compared to 30.3% in Q2 2020.
Adjusted EBITDA was $11.4 million, compared to an adjusted EBITDA loss of $1.1 million in Q2 2020.
Beauty Health
Beauty Health
Beauty Health Revenue by Segment
Beauty Health Revenue by Geographic Location
Forward Guidance
BeautyHealth is raising its fiscal 2021 net sales guidance to $230 million to $240 million and expects adjusted EBITDA of approximately $25 million.
Positive Outlook
- Raising fiscal 2021 net sales guidance to $230 million to $240 million.
- Expects adjusted EBITDA of approximately $25 million.
- Anticipates up to $15 million of capital expenditures.
- Assumes a largely reopened global market.
- Reinvesting in global infrastructure scaling for future growth.
Challenges Ahead
- Achievement of anticipated results is subject to risks and uncertainties.
- Cautious of potential risk for further market closures or other restrictive measures from new COVID-19 strains.
- Uneven global rollout and adoption of the vaccines may impact results.
- Outlook does not take into account the impact of any unanticipated developments in the business or changes in the operating environment.
- Outlook does not take into account any unannounced acquisitions, dispositions, or financings during 2021.
Revenue & Expenses
Visualization of income flow from segment revenue to net income